Drug · DIN 02187108
SYNPHASIC 21 TABLETS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 3, 2009; first marketed August 14, 1996.
- Drug Identification Number (DIN)
- 02187108
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Norethisterone and estrogen G03AB04
- Class
- Human
- Record last updated
- September 24, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORETHINDRONE | 0.5 MG | |
| ETHINYL ESTRADIOL | 0.035 MG | |
| NORETHINDRONE | 1.0 MG | |
| ETHINYL ESTRADIOL | 0.035 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 14, 2003: NOC 3372New Drug Submission (NDS) · Manufacturer name change
- August 24, 2001: NOC 2470New Drug Submission (NDS) · Manufacturer name change
- October 31, 1995: NOC 5178New Drug Submission (NDS)
Other DINs named SYNPHASIC 21 TABLETS
- DIN 00620947 · Cancelled Post Market